Composition for Treating Neurodegenerative Diseases
Resorcinol-based products for preventing and/or treating neuroinflammation and treating neurodegenerative diseases
Published: 16th September 2022

Patents
- EP22166594.6
- PT11701 (Priority date: 21/02/2022)
IP Status
- Patented
Seeking
- Development partner
- Licensing